Home > Drug Search >
  • company_query: Antisense Therapeutics
  •   > 
Drug Filter
Category:
chemistry (27) biology (5)
Status:
Approved (1) NDA Filing (1) Phase Ⅲ (2) Phase Ⅱ (15) Phase Ⅰ (12) IND Filing (1)
Clinical Stage:
Pending (4) Active (19) Discontinued (8)
Bio-Type:
Gene therapy (1) Recombinant cytokines (1) Recombinant glycoprotein (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Anemia (1) Chronic lymphocytic leukemia (CLL) (1) Clostridium difficile infection (1) Colorectal neoplasms (1) Duchenne muscular dystrophy (DMD) (1) Endometrial cancer (1) Epidermolysis bullosa (1) Erectile dysfunction (ED) (2) Erosive esophagitis (EE) (1) Gastroesophageal reflux disease (GERD) (2) Metastatic breast cancer (1) Non small cell lung cancer (NSCLC) (2) Ovarian cancer (1) Peptic ulcer (1) Periodontitis (1) Prostate cancer (1) Psoriasis (1) Pulmonary arterial hypertension (1) Mucopolysaccharidosis III (2) Small cell lung cancer (SCLC) (1) Solid tumours (4) Head and neck cancer (1) Colorectal cancer (1) Biliary cancer (1) Hematological cancer (1) Hereditary angioedema (HAE) (1) Terminate pregnancy (1) Neuroendocrine tumors (NET) (1) Gingival diseases (1) Gastrointestinal disorders (1) Hypogonadism (1) Postmenopausal syndrome (1) hematological malignancies (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top